Thomas Haberberger

994 total citations · 1 hit paper
8 papers, 844 citations indexed

About

Thomas Haberberger is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, Thomas Haberberger has authored 8 papers receiving a total of 844 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 2 papers in Dermatology. Recurrent topics in Thomas Haberberger's work include Connective Tissue Growth Factor Research (3 papers), Systemic Sclerosis and Related Diseases (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Thomas Haberberger is often cited by papers focused on Connective Tissue Growth Factor Research (3 papers), Systemic Sclerosis and Related Diseases (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Thomas Haberberger collaborates with scholars based in United States, Germany and United Kingdom. Thomas Haberberger's co-authors include Irina Sorokina, David C. Gervasi, Volkmar Günzler, William G. Kaelin, Mircea Ivan, Joan Conaway, Haifeng Yang, Ronald Conaway, Keiichi Kondo and Richard Stratton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Thomas Haberberger

8 papers receiving 821 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor

2002 478 citations Mircea Ivan, Thomas Haberberger et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Haberberger United States	7	486	418	172	135	126	8	844
Lynette J. Schedlich Australia	13	659 1.4×	282 0.7×	145 0.8×	177 1.3×	45 0.4×	16	1.2k
Kerstin Enquist Sweden	15	476 1.0×	384 0.9×	117 0.7×	60 0.4×	141 1.1×	18	868
A Gockerman United States	9	772 1.6×	391 0.9×	186 1.1×	52 0.4×	44 0.3×	10	1.5k
Youwen Yang United Kingdom	18	671 1.4×	153 0.4×	281 1.6×	108 0.8×	60 0.5×	22	982
Ben Kinnersley United Kingdom	15	465 1.0×	267 0.6×	217 1.3×	104 0.8×	284 2.3×	26	902
Karoline J. Briegel United States	17	720 1.5×	191 0.5×	110 0.6×	111 0.8×	50 0.4×	28	1.0k
David Van Mater United States	14	540 1.1×	143 0.3×	76 0.4×	152 1.1×	61 0.5×	24	869
Sébastien Toffoli Belgium	9	281 0.6×	319 0.8×	83 0.5×	93 0.7×	43 0.3×	14	576
Ryosuke Osada Japan	13	481 1.0×	192 0.5×	46 0.3×	97 0.7×	57 0.5×	20	807
Yiqin Xiong United States	10	1.0k 2.1×	475 1.1×	201 1.2×	144 1.1×	46 0.4×	31	1.3k

Countries citing papers authored by Thomas Haberberger

Since Specialization

Citations

This map shows the geographic impact of Thomas Haberberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Haberberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Haberberger more than expected).

Fields of papers citing papers by Thomas Haberberger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Haberberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Haberberger. The network helps show where Thomas Haberberger may publish in the future.

Co-authorship network of co-authors of Thomas Haberberger

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Haberberger. A scholar is included among the top collaborators of Thomas Haberberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Haberberger. Thomas Haberberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Bonniaud, Philippe, Peter J. Margetts, Thomas Haberberger, et al.. (2003). Adenoviral Gene Transfer of Connective Tissue Growth Factor in the Lung Induces Transient Fibrosis. American Journal of Respiratory and Critical Care Medicine. 168(7). 770–778. 114 indexed citations

2.

Ivan, Mircea, Thomas Haberberger, David C. Gervasi, et al.. (2002). Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proceedings of the National Academy of Sciences. 99(21). 13459–13464. 478 indexed citations breakdown →

3.

Stratton, Richard, Shiwen Xu, Giorgia Martini, et al.. (2001). Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients. Journal of Clinical Investigation. 108(2). 241–250. 26 indexed citations

4.

Stratton, Richard, Shiwen Xu, Giorgia Martini, et al.. (2001). Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients. Journal of Clinical Investigation. 108(2). 241–250. 169 indexed citations

5.

Temme, Achim, Thomas Ott, Thomas Haberberger, Otto Traub, & Klaus Willecke. (2000). Acute-phase response and circadian expression of connexin26 are not altered in connexin32-deficient mouse liver. Cell and Tissue Research. 300(1). 111–117. 18 indexed citations

6.

Temme, Achim, Thomas Ott, Thomas Haberberger, Otto Traub, & Klaus Willecke. (2000). Acute-phase response and circadian expression of connexin26 are not altered in connexin32-deficient mouse liver. Cell and Tissue Research. 300(1). 111–117. 22 indexed citations

7.

Hosono, Makoto, Paul O. Zamora, Stefan Guhlke, et al.. (1998). Localization of colorectal carcinoma by rhenium-188-labeled B72.3 antibody in xenografted mice. Annals of Nuclear Medicine. 12(2). 83–88. 3 indexed citations

8.

Hosono, Makoto, Makoto Hosono, Masako Hosono, et al.. (1996). Localization of Small‐cell Lung Cancer Xenografts with Iodine‐125‐, Indium‐111‐, and Rhenium‐188‐Somatostatin Analogs. Japanese Journal of Cancer Research. 87(9). 995–1000. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact